These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
228 related articles for article (PubMed ID: 26195204)
61. A dietary survey of an isolated population in the UK: the islanders of Orkney. Barber SA; Bull NL; Cameron AM Hum Nutr Appl Nutr; 1986 Dec; 40(6):462-9. PubMed ID: 3027007 [TBL] [Abstract][Full Text] [Related]
62. Comparison of dietary protein with an oral, branched chain-enriched amino acid supplement in chronic portal-systemic encephalopathy: a randomized controlled trial. Horst D; Grace ND; Conn HO; Schiff E; Schenker S; Viteri A; Law D; Atterbury CE Hepatology; 1984; 4(2):279-87. PubMed ID: 6706302 [TBL] [Abstract][Full Text] [Related]
64. The effects of diet differing in fat, carbohydrate, and fiber on carbohydrate and lipid metabolism in type II diabetes. O'Dea K; Traianedes K; Ireland P; Niall M; Sadler J; Hopper J; De Luise M J Am Diet Assoc; 1989 Aug; 89(8):1076-86. PubMed ID: 2547860 [TBL] [Abstract][Full Text] [Related]
65. Influence of the metabolic complications of liver cirrhosis on dietary intake. Tözün N Med Sci Monit; 2000; 6(6):1223-6. PubMed ID: 11208483 [TBL] [Abstract][Full Text] [Related]
66. Severe recurrent hepatic encephalopathy that responded to oral branched chain amino acids. Chalasani N; Gitlin N Am J Gastroenterol; 1996 Jun; 91(6):1266-8. PubMed ID: 8651189 [TBL] [Abstract][Full Text] [Related]
67. [Metabolic disturbances in liver cirrhosis (part 1)--hepatic osteopathy and malnutrition]. Gundling F; Seidl H; Löffler N; Strassen I; Schepp W Dtsch Med Wochenschr; 2009 Nov; 134(48):2461-4. PubMed ID: 19924612 [TBL] [Abstract][Full Text] [Related]
68. [Importance of nutritional support in patients with hepatic encephalopathy]. Jurado García J; Costán Rodero G; Calañas-Continente A Nutr Hosp; 2012; 27(2):372-81. PubMed ID: 22732958 [TBL] [Abstract][Full Text] [Related]
69. Role of branched-chain amino acids in liver disease: the evidence for and against. Khanna S; Gopalan S Curr Opin Clin Nutr Metab Care; 2007 May; 10(3):297-303. PubMed ID: 17414498 [TBL] [Abstract][Full Text] [Related]
70. Diets affecting treatment of parkinsonism with levodopa. Gillespie NG; Mena I; Cotzias GC; Bell MA J Am Diet Assoc; 1973 May; 62(5):525-8. PubMed ID: 4572702 [No Abstract] [Full Text] [Related]
71. Hepatic Encephalopathy. Blei AT; Córdoba J; Am J Gastroenterol; 2001 Jul; 96(7):1968-76. PubMed ID: 11467622 [TBL] [Abstract][Full Text] [Related]
72. Effect of vegetable and animal protein diets in chronic hepatic encephalopathy. Greenberger NJ; Carley J; Schenker S; Bettinger I; Stamnes C; Beyer P Am J Dig Dis; 1977 Oct; 22(10):845-55. PubMed ID: 335882 [No Abstract] [Full Text] [Related]
77. Comparison of animal and vegetable protein sources in the dietary management of hepatic encephalopathy. Shaw S; Worner TM; Lieber CS Am J Clin Nutr; 1983 Jul; 38(1):59-63. PubMed ID: 6858955 [TBL] [Abstract][Full Text] [Related]
78. The impact of L-branched-chain amino acids and L-leucine on malnutrition, sarcopenia, and other outcomes in patients with chronic liver disease. Dos Santos ALS; Anastácio LR Expert Rev Gastroenterol Hepatol; 2021 Feb; 15(2):181-194. PubMed ID: 32993404 [TBL] [Abstract][Full Text] [Related]